ORYZON to Participate in Upcoming Events in January
Globenewswire·2026-01-08 13:00
MADRID and CAMBRIDGE, Mass., Jan. 08, 2026 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and global leader in epigenetics, announced today that its management will participate at the following upcoming events: 9th Sachs Annual Neuroscience Innovation Forum, January 11Location: Marines’ Memorial Club, San Francisco, USAPresentation type: Company presentationPresentation time: 10:35 am (PST) 44th Annual J.P. Morgan Healthcare Conference, J ...